NCT07100418

A Clinical Study Evaluating the Efficacy and Safety of HRS-7249 in Treating Patients With Hyperlipidemia

A Multicenter, Randomized, Placebo-controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of HRS-7249 in Patients With Hyperlipidemia

• Status: Recruiting
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 200 (estimated)
• Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. · Industry
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

The study is being conducted to evaluate the efficacy and safety of HRS-7249 for patients with hyperlipidemia, and to explore the reasonable dosage of HRS-7249 for patients with hyperlipidemia.

Conditions

• Hyperlipidemia

Interventions

Type	Name	Description
DRUG	HRS-7249 Injection	HRS-7249 injection.
DRUG	Sodium Chloride Injection	Sodium chloride injection.

Timeline

• Start date: 2025-08-12
• Primary completion: 2026-09-01
• Completion: 2027-01-01
• First posted: 2025-08-03
• Last updated: 2025-09-10

Locations

1 site across 1 country: China